McKesson Corporation
MCK Healthcare Medical Distribution
McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025. In the quarter to June 2026, revenue grew 7.72%, EPS fell 17.7%, free cash flow grew 66.4% and total debt rose 10.5%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for ten.
Follow MCK
McKesson Corporation (MCK) Revenue
McKesson Corporation's revenue for fiscal 2026 was $403.4B, up 12.4% from $359.1B in fiscal 2025. Over the twelve months to 30 June 2026 it was $411.0B. Over the past ten years it has ranged from $179.0B (fiscal 2015) to $403.4B (fiscal 2026) — the current reading is the highest in ten years. Revenue has risen for 11 consecutive fiscal years. McKesson Corporation ranks 1st of 10 Medical Distribution companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2026 | $403.4B | 12.36% |
| FY2025 | $359.1B | 16.22% |
| FY2024 | $309.0B | 11.65% |
| FY2023 | $276.7B | 4.83% |
| FY2022 | $264.0B | 10.80% |
| FY2021 | $238.2B | 3.11% |
| FY2020 | $231.1B | 7.81% |
| FY2019 | $214.3B | 2.86% |
| FY2018 | $208.4B | 4.95% |
| FY2017 | $198.5B | 4.01% |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Jun 2026 | $105.4B | 9.43% |
| Mar 2026 | $96.3B | (9.29%) |
| Dec 2025 | $106.2B | 2.92% |
| Sep 2025 | $103.2B | 5.44% |
| 42 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| MCK McKesson Corporation | $411.0B |
| COR Cencora, Inc. compare | $332.8B |
| CAH Cardinal Health, Inc. compare | $254.2B |
| HSIC Henry Schein, Inc. compare | $13.6B |
| ACH Accendra Health, Inc. compare | $2.6B |
| FOCL FocalTherics compare | $77.8M |
| COSM Cosmos Health Inc. compare | $73.7M |
| AHG Akso Health Group Sponsored ADR compare | $20.1M |
| HKPD Cellyan Biotechnology Co., Ltd compare | — |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on MCK
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement